Open Access. Powered by Scholars. Published by Universities.®
- Institution
- Publication Type
Articles 1 - 4 of 4
Full-Text Articles in Medicine and Health Sciences
Abortion Pills, David S. Cohen, Greer Donley, Rachel Rebouché
Abortion Pills, David S. Cohen, Greer Donley, Rachel Rebouché
Articles
Abortion is now illegal in roughly a third of the country, but abortion pills are more widely available than ever before. Though antiabortion advocates and legislators are attacking pills with all manner of strategies, clinics, websites, and informal networks are openly facilitating the distribution of abortion pills, legally and illegally, across the United States. This Article is the first to explain this defining aspect of the post-Roe environment and the novel issues it raises at the level of state law, federal policy, and on-the-ground advocacy.
This Article first details antiabortion strategies to stop pills by any means necessary. These tactics …
The Promise Of Telehealth For Abortion, Greer Donley, Rachel Rebouché
The Promise Of Telehealth For Abortion, Greer Donley, Rachel Rebouché
Book Chapters
The COVID-19 pandemic catalyzed a transformation of abortion care. For most of the last half century, abortion was provided in clinics outside of the traditional healthcare setting. Though a medication regimen was approved in 2000 that would terminate a pregnancy without a surgical procedure, the Food & Drug Administration required, among other things, that the drug be dispensed in person. This requirement dramatically limited the medication’s promise to revolutionize abortion because it subjected medication abortion to the same physical barriers of procedural care.
Over the course of the COVID-19 pandemic, however, that changed. The pandemic’s early days exposed how the …
Medication Abortion Exceptionalism, Greer Donley
Medication Abortion Exceptionalism, Greer Donley
Articles
Restrictive state abortion laws garner a large amount of attention in the national conversation and legal scholarship, but less known is a federal abortion policy that significantly curtails access to early abortion in all fifty states. The policy limits the distribution of mifepristone, the only drug approved to terminate a pregnancy so long as it is within the first ten weeks. Unlike most drugs, which can be prescribed by licensed healthcare providers and picked up at most pharmacies, the Food and Drug Administration only allows certified providers to prescribe mifepristone, and only allows those providers to distribute the drug to …
The Public Health Turn In Reproductive Rights, Rachel Rebouché
The Public Health Turn In Reproductive Rights, Rachel Rebouché
Washington and Lee Law Review
Over the last decade, public health research has demonstrated the short-term, long-term, and cumulative costs of delayed or denied abortion care. These costs are imposed on people who share common characteristics: abortion patients are predominantly low income and disproportionately people of color. Public health evidence, by establishing how law contributes to the scarcity of services and thereby entrenches health disparities, has vividly highlighted the connections between abortion access, race, and income. The contemporary attention to abortion law’s relationship to inequality is no accident: researchers, lawyers, and advocates have built an infrastructure for generating credible empirical studies of abortion restrictions’ effects. …